1. Ketamine Analog Methoxetamine Induced Inflammation and Dysfunction of Bladder in Rats
    Qiang Wang et al, 2017, IJMS CrossRef
  2. Abnormal Sensory Protein Expression and Urothelial Dysfunction in Ketamine-Related Cystitis in Humans
    Yao Chou Tsai et al, 2016, Int Neurourol J CrossRef
  3. Regulatory effects of anesthetics on nitric oxide
    Wenguo Fan et al, 2016, Life Sciences CrossRef
  4. Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis
    Zhi Ye et al, 2018, Neuropharmacology CrossRef
  5. The Immunomodulatory Imbalance in Patients with Ketamine Cystitis
    Gang-Yi Fan et al, 2017, BioMed Research International CrossRef
  6. Special K: once the fun is over an EMT arrives for the bladder
    Warren G. Hill et al, 2017, American Journal of Physiology-Renal Physiology CrossRef
  7. Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction
    Retnagowri Rajandram et al, 2016, American Journal of Physiology-Renal Physiology CrossRef
  8. Histopathological characteristics of ketamine-associated uropathy and their clinical association
    Jia-Fong Jhang et al, 2018, Neurourology and Urodynamics CrossRef
  9. Potential Orphan Drug Therapy of Intravesical Liposomal Onabotulinumtoxin-A for Ketamine-Induced Cystitis by Mucosal Protection and Anti-inflammation in a Rat Model
    Wei-Chia Lee et al, 2018, Sci Rep CrossRef
  10. Recent advances in imaging and understanding interstitial cystitis
    Pradeep Tyagi et al, 2018, F1000Res CrossRef
  11. Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell proliferation and collagen accumulation
    Junyu Lai et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  12. Ketamine cystitis—A long-lasting burning issue in Taiwan
    En Meng, 2015, Urological Science CrossRef
  13. Ketamine-Associated Uropathy: From Presentation to Management
    Chi-hang Yee et al, 2016, Curr Bladder Dysfunct Rep CrossRef
  14. Ketamine
    Frank Anthony Myers et al, 2016, Clinics in Laboratory Medicine CrossRef
  15. Ba‐Wei‐Die‐Huang‐Wan (Hachimi‐jio‐gan) can ameliorate ketamine‐induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model
    Wei‐Chia Lee et al, 2019, Neurourology and Urodynamics CrossRef
  16. Analgesic and anti-inflammatory properties of hydroalcoholic extracts of Malva sylvestris, Carum carvi or Medicago sativa, and their combination in a rat model
    Masoud Seddighfar et al, 2020, Journal of Integrative Medicine CrossRef
  17. What urologists need to know about ketamine-induced uropathy: A systematic review
    Daniele Castellani et al, 2020, Neurourology and Urodynamics CrossRef
  18. Clinico‐pathological correlation of optical fluorescence imaging in oral mucosal lesions
    Lalima Tiwari et al, 2020, Oral Dis CrossRef
  19. Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas
    Maria Ramnefjell et al, 2017, Oncotarget CrossRef
  20. Ketamine‑induced bladder dysfunction is associated with extracellular matrix accumulation and impairment of calcium signaling in a mouse model
    Cheng‑Huang Shen et al, 2019, Mol Med Report CrossRef
  21. Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis
    Chi‑Jung Huang et al, 2017, Int J Mol Med CrossRef
  22. Active Pharmaceutical Ingredient Poly(ionic liquid)-based Microneedles for the Treatment of Skin Acne Infection
    Tikai Zhang et al, 2020, Acta Biomaterialia CrossRef
  23. Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology
    Huan Chen et al, 2020, Nat Commun CrossRef
  24. Nerve allograft histology after banking following complicated reconstruction
    David P. Foley et al, 2020, Clin Case Rep CrossRef
  25. Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
    Jason Ng et al, 2021, Psychopharmacology CrossRef
  26. Oxidation‐Responsive, Tunable Growth Factor Delivery from Polyelectrolyte‐Coated Implants
    John R. Martin et al, 2021, Adv. Healthcare Mater. CrossRef
  27. Quantification of the Inflammatory Responses to Pro-and Anti-Inflammatory Agents in Manila clam, Ruditapes philippinarum
    Seung-Hyeon Kim et al, 2021, Fish & Shellfish Immunology CrossRef
  28. Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis
    Xiang Xie et al, 2021, FASEB j. CrossRef
  29. Efficacy and safety of a novel hemostatic material, BoneStat, compared with Ostene and Bone Wax in a rat calvarial defect model
    Seon Young Choi et al, 2021, Int J Artif Organs CrossRef
  30. null
    Daniele Castellani, 2022 CrossRef
  31. Molecular Pathophysiology and Potential Therapeutic Strategies of Ketamine-Related Cystitis
    Chin-Li Chen et al, 2022, Biology CrossRef
  32. Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis
    Megan Perkins et al, 2022, Front. Syst. Neurosci. CrossRef
  33. Effect of Doxycycline-Release Anastomotic Augmentation Ring on Porcine Colorectal Anastomosis
    Martin Luchtefeld et al, 2022, Journal of Surgical Research CrossRef
  34. Nanolipogel Loaded with Tea Tree Oil for the Management of Burn: GC-MS Analysis, In Vitro and In Vivo Evaluation
    Rabab Kamel et al, 2022, Molecules CrossRef
  35. null
    Daniele Castellani, 2022 CrossRef
  36. Toxicity patterns associated with chronic ketamine exposure
    Alexandre Hottat et al, 2023, Toxicologie Analytique et Clinique CrossRef